ID   NCI-BL1450
AC   CVCL_2640
SY   BL1450; NCI-BL7; BL7
DR   CLO; CLO_0007962
DR   ATCC; CRL-5951
DR   BioSample; SAMN03472614
DR   Wikidata; Q54907723
RX   PubMed=1565469;
RX   PubMed=8806092;
RX   PubMed=9559342;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): ATCC=CRL-5951
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 12,13
ST   D16S539: 12
ST   D18S51: 12
ST   D19S433: 14,15
ST   D21S11: 28,31.2
ST   D2S1338: 18,23
ST   D3S1358: 15,18
ST   D5S818: 11,13
ST   D7S820: 11,12
ST   D8S1179: 12,13
ST   FGA: 21,27
ST   Penta D: 11,12
ST   Penta E: 10,14
ST   TH01: 9.3
ST   TPOX: 8,9
ST   vWA: 17,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A466 ! NCI-H1450
OI   CVCL_A495 ! NCI-H1451
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 17
//
RX   PubMed=1565469;
RA   Bodner S.M., Minna J.D., Jensen S.M., D'Amico D., Carbone D.P.,
RA   Mitsudomi T., Fedorko J., Buchhagen D.L., Nau M.M., Gazdar A.F.,
RA   Linnoila R.I.;
RT   "Expression of mutant p53 proteins in lung cancer correlates with the
RT   class of p53 gene mutation.";
RL   Oncogene 7:743-749(1992).
//
RX   PubMed=8806092; DOI=10.1002/jcb.240630505;
RA   Phelps R.M., Johnson B.E., Ihde D.C., Gazdar A.F., Carbone D.P.,
RA   McClintock P.R., Linnoila R.I., Matthews M.J., Bunn P.A. Jr.,
RA   Carney D.N., Minna J.D., Mulshine J.L.;
RT   "NCI-Navy Medical Oncology Branch cell line data base.";
RL   J. Cell. Biochem. 63 Suppl. 24:32-91(1996).
//
RX   PubMed=9559342; DOI=10.1002/(SICI)1098-2264(199804)21:4<308::AID-GCC4>3.0.CO;2-2;
RA   Virmani A.K., Fong K.M., Kodagoda D.R., McIntire D., Hung J., Tonk V.,
RA   Minna J.D., Gazdar A.F.;
RT   "Allelotyping demonstrates common and distinct patterns of chromosomal
RT   loss in human lung cancer types.";
RL   Genes Chromosomes Cancer 21:308-319(1998).
//